NETCast Podcasting4Associations

Join us for Episode 20 of NETCast. Today we are excited to bring a live taping from the NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS.

Our guest moderator is Aman Chuahan, MD, is a medical oncologist at University of Miami, Leader of the Neuroendocrine Cancer Program and co-leader of the Diagnostic Drug Development program at Sylvester Comprehensive Cancer Center, and Co-Chair of NANETS Communications Committee.

He is joined by guest participants who attended ENETS and will share some of their impressions:

Jaydira del Rivero, MD, Asst. Research Physician and Director Rare Tumor Clinic, Center for Cancer Research, National Cancer Institute, and member of NANETS’ Executive Board of Directors;

Thorvardur Halfdanarson, MD, Medical Oncology, Associate Professor, Mayo Clinic, President, NANETS Board of Directors; and

Simron Singh, MD, MPH, FRCPC, Medical Oncologist, Odette Cancer Center at Sunnybrook Health Sciences Center, Adjunct Professor, University of Toronto, and Secretary of NANETS’ Board of Directors.

Today’s topic is sure to engage many of you who were unable to attend the ENETS conference, and many of you who will want to tune in to hear about things you may have missed at the conference!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Jason Starr. medical oncologist with Mayo Clinic, and Chair of NANETS Communications Committee, talks with NANETS Communications Director Maureen Werther about their goals and projects planned for 2024. Collaboration is the key focal point in '24. Tune in and learn about upcoming webinars, podcasts, programs and events that will be hosted jointly with our partners in the neuroendocrine field.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Simron Singh is a medical oncologist, affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute, and an assistant professor at the University of Toronto. Dr. Singh is a longtime member of NANETS and the current Treasurer of its Board of Directors.

Dr. Alexandria T. Phan is a Professor of Internal Medicine and Medical Oncology at Froedtert & Medical College of Wisconsin, with a special focus on neuroendocrine tumors and malignancies of the GI tract. Dr. Phan is a member of NANETS' Communications and the moderator of this discussion. The doctors will discuss highlights from the recent ASCO meeting, with a special focus on the results of the phase 3 randomized NETTER-2 study. This is the first randomized study to demonstrate efficacy of RLT as 1L treatment in any malignancy and will change clinical practice.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

NET medical professionals gathered in Detroit in November 2023 to discuss highlights from NANETS' 2023 Multidisciplinary NET Medical Symposium held the previous month in Montreal. Internationally renowned cancer researcher and medical oncologist, Philip A. Philip, MD, PhD, Wayne State University, moderated a discussion with fellow NET medical professionals: Jonathan Strosberg, MD, who leads Moffitt’s Neuroendocrine Tumor Division and Department of Gastrointestinal Oncology Research Program; and Amr Mohamed, MD, Director of the Neuroendocrine Tumor Program at University Hospitals Seidman Cancer Center. Topics included surgical treatment for G3 NENs, ongoing and recently completed clinical trials that have the potential to change the current landscape for NENs, and more cutting-edge topics.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Here’s the latest episode of NETCast, recorded live at #NANETS 2023 Symposium in Montreal. Guest moderator, Dr. David Zhen, GI, Medical Oncology, Fred Hutchinson Cancer Center, is joined by Dr. Jennifer Eads, MD, Medical Oncology, Penn Medicine, Dr. Jennifer Chan, Medical Oncology, Dana-Farber Cancer Institute, and Josh Mailman,fierce patient advocate and President of the NET advocacy group NorCal CarciNET for an eye-opening conversation about ongoing/upcoming clinical trials, challenges facing both investigators and patients for NET clinical trials, and most importantly, implications for patients.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Gaby Gabriel, Associate Professor of Radiology and Surgery at U. of Kentucky, and member, NANETS Communications Committee, is our guest moderator for this commonly encountered management decision in NETs. He is joined by a distinguished panel of guest discussants: Dr. Callisia Clarke, Surgical Oncology, Medical College of Wisconsin; Dr. Nicholas Fidelman, Interventional Radiology, UCSF; and Dr. Michael Soulen, Interventional Radiology, Penn Medicine.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.